BackInterpace Biosciences Overview

Interpace Biosciences Total Liabilities

Latest total liabilities for IDXG: $10M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$10.33M
31.50% YoYΔ $-4.75M vs prior year quarter

Peer average / median

Loading

Interpace Biosciences Total Liabilities History

Loading

Interpace Biosciences vs. peers: Total Liabilities Comparison

Loading

Interpace Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Interpace Biosciences (IDXG) FAQ

As of the most recent data (March 2026), IDXG shows a total liabilities of $10M. That compares with $15M in the prior-year period — down 31.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IDXG's total liabilities is now $10M (was $15M) — a 31.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Interpace Biosciences is outperforming or lagging.

Tracking IDXG's total liabilities over time shows whether Interpace Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $10M That compares with $15M in the prior-year period — down 31.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Interpace Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $10M) with ownership activity and broader fundamentals.